ITelagen Named to the CRN Fast Growth 150 List

ITelagen, Inc., a leading provider of IT support and cloud-based hosting for healthcare, finance and small business, announces that it has been named to the 2013 CRN Fast Growth 150 list. The annual list features the fastest-growing solution providers in the technology industry based on two years' growth of net sales from fiscal year 2010 to fiscal year 2012. ITelagen grew 144.45% through new partnerships, expanded services, and product offerings.

In August 2013, ITelagen announced the release of UroWorx™, a series of urology-focused templates geared toward enhancing the use of NextGen® Ambulatory EHR for urologists, and more recently creating buzz is the announcement of ITelagen’s innovative EHRAnywhere™ platform, a technology that delivers EHR and healthcare applications to iPad and Android mobile devices.

“The success and growth of ITelagen in the past year has been strongly attributed to the desire to empower physicians to create efficiencies and mobility in their delivery of patient care. Our clients seek immediacy with accuracy, streamlined workflows paired with quality, and growing revenues. The ever-increasing line of products and services available with ITelagen all have one thing in common: the client,” expresses John O’Keefe, CEO of ITelagen.

“Despite the challenges of an evolving market, these Fast Growth companies demonstrate an unmatched ability to nimbly and effectively respond to market demands, fulfill customer needs and remain steadfast in their commitment to innovation,” said Robert Faletra, CEO, CRN. “We are thrilled to shine a spotlight on the successful companies that keep the channel top of mind and serve as an example for the rest of the market.”

A sampling of the 2013 Fast Growth list is featured in the September issue of CRN Magazine and is featured online at http://www.crn.com. The complete list of 150 companies will be available in the CRN Tech News app, available for iPad and Windows 8.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.